SEYED JALALI to Immunotherapy
This is a "connection" page, showing publications SEYED JALALI has written about Immunotherapy.
Connection Strength
0.213
-
Hypoxia and programmed cell death-ligand 1 expression in the tumor microenvironment: a review of the effects of hypoxia-induced factor-1 on immunotherapy. Mol Biol Rep. 2024 Jan 06; 51(1):88.
Score: 0.145
-
Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine. J Cell Mol Med. 2018 01; 22(1):558-567.
Score: 0.024
-
Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies. Nanomedicine. 2017 Nov; 13(8):2671-2682.
Score: 0.023
-
Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model. Int J Pharm. 2015 Nov 10; 495(1):162-170.
Score: 0.020